Actively Recruiting
Intra Artherial Therapies in Treatment of Primary Liver Diseases: an Observational Study
Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2025-01-14
3300
Participants Needed
1
Research Sites
466 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this observational study is to learn what are the best conditions that will give a positive outcome to men and women that receive a intra arterial therapy (IAT) for primary liver cancer. Intra arterial therapies are radiologic procedures that block liver cancer blood supply. The researchers will collect the data of participants located in the Radiology department in "IRCCS Azienda Ospedaliera Universitaria" Hospital in Bologna and will study clinic and radiological traits to understand which is the best case scenario for a optimal treatment response.
CONDITIONS
Official Title
Intra Artherial Therapies in Treatment of Primary Liver Diseases: an Observational Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of hepatocellular carcinoma (HCC) or intrahepatic cholangiocarcinoma (iCCA) with clinical indication to receive or having received trans-arterial embolization (TAE), transarterial chemoembolization (TACE), transarterial radioembolization (TARE), or drug-eluting beads chemoembolization (DEB-TACE)
- Age over 18 years
- Ability to give informed consent
You will not qualify if you...
- Presence of shunt in gastrointestinal arteries that cannot be embolized
- Metastasis spread outside of the liver
- Liver failure
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Italy, 40138
Actively Recruiting
Research Team
C
Cristina Mosconi, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here